Wolters Kluwer Announces Partnership with the FNCP to Improve Clinical Decision-Making in Spain

Wolters KluwerWolters Kluwer, a leading global provider of information for healthcare professionals and students, has announced a new partnership with the Federación Nacional de Clínicas Privadas (FNCP), an organization representing over 550 of the private healthcare institutions in Spain.

The collaboration reflects Wolters Kluwer's focus on fostering growth in the Spanish market and broadening adoption of UpToDate®, the clinical decision support resource used by more than 1 million doctors worldwide. The partnership supports a common mission of the FNCP and Wolters Kluwer to improve care in hospitals and clinics across the country.

Carlos Rus, managing director of FNCP, commented that it is essential to support "any option to improve patient care and promote excellence in healthcare. For the FNCP, it is very important to offer our members services like this, that can bring agility, information, knowledge, safety and quality, to both managers and health centers as well as patients themselves."

As the FNCP strategically focuses on ensuring a higher quality of care and better health outcomes, UpToDate helps member institutions realize these goals by equipping clinicians with access to the most current clinical recommendations to make the best decisions for patients. Working with the FNCP also complements access to UpToDate currently available at over 300 healthcare sites in the Sistema Nacional de Salud (SNS), Spain's national health system operated by Spain's Ministry of Health, Social Services and Equality.

"UpToDate provides clinicians throughout Spain with evidence-based recommendations to make better care decisions for their patients," says Denise Basow, MD, Vice President and General Manager, UpToDate at Wolters Kluwer, Clinical Solutions. "Our partnership with the FNCP forms an important part of our mission to improve the quality and effectiveness of healthcare throughout Spain."

About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...